| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
|---|---|
| Contact name | Belinda Jim |
| Contact phone | 718-918-5762 |
| Contact email | belinda_bun_jim@yahoo.com |
| Dua signed dt | Aug. 17, 2009, midnight |
| Site approved dt | Dec. 17, 2008, midnight |
| Niddk signed dt | Aug. 20, 2009, midnight |